Because the human in vivo level of SCF in serum is between 1 ng/mL and 3 ng/mL [34-36], serum SCF concentration may be high enough to stimulate the proliferation and invasion of pancreatic cancer cells in vivo. Here, KITLG is linked to pancreatic neoplasm.